Time-dependent activation of prostacyclin and nitric oxide pathways during continuous i.v. infusion of serelaxin (recombinant human H2 relaxin)
about
Serelaxin treatment reverses vascular dysfunction and left ventricular hypertrophy in a mouse model of Type 1 diabetes.Serelaxin Treatment Reduces Oxidative Stress and Increases Aldehyde Dehydrogenase-2 to Attenuate Nitrate Tolerance.Vascular actions of relaxin: nitric oxide and beyond.Does serelaxin treatment alter passive mechanical wall properties in small resistance arteries?Relaxin-2 in Cardiometabolic Diseases: Mechanisms of Action and Future PerspectivesRelaxin deficiency attenuates pregnancy-induced adaptation of the mesenteric artery to angiotensin II in mice.Short-term (48 hours) intravenous serelaxin infusion has no effect on myogenic tone or vascular remodeling in rat mesenteric arteries.Relaxin as a Therapeutic Target for the Cardiovascular Complications of Diabetes.Relaxin Deficiency Leads to Uterine Artery Dysfunction During Pregnancy in Mice.RXFP1 Receptor Activation by Relaxin-2 Induces Vascular Relaxation in Mice a Gα-Protein/PI3Kß/γ/Nitric Oxide-Coupled Pathway
P2860
Q37571303-24160761-2BE3-4FB8-9EDF-A63704F61DECQ37712528-8B4E3AC9-BCA4-457D-A413-6B61FEE5010BQ38945156-88B339F0-8D90-4216-A6DB-77C6BA7CD294Q38960703-616642D7-514E-4372-8613-B612632651DAQ41463324-FE685106-F9F9-4EEE-99D8-03D16AC75864Q46586252-A11A732A-E444-45B1-9F1E-AD4F7949DCC4Q48331109-E5F84511-925A-4E9E-BBEE-5C8FA3D577F3Q55209012-3B183DC8-14C7-44FB-B928-793E00E18D75Q55242384-AAA0A33C-3701-4E0F-8361-B75B77B867AFQ58764679-493C45D7-8B3C-45EC-8963-A85952652E7C
P2860
Time-dependent activation of prostacyclin and nitric oxide pathways during continuous i.v. infusion of serelaxin (recombinant human H2 relaxin)
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 December 2015
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Time-dependent activation of p ...... (recombinant human H2 relaxin)
@en
Time-dependent activation of p ...... ous i.v. infusion of serelaxin
@nl
type
label
Time-dependent activation of p ...... (recombinant human H2 relaxin)
@en
Time-dependent activation of p ...... ous i.v. infusion of serelaxin
@nl
prefLabel
Time-dependent activation of p ...... (recombinant human H2 relaxin)
@en
Time-dependent activation of p ...... ous i.v. infusion of serelaxin
@nl
P2093
P2860
P356
P1476
Time-dependent activation of p ...... (recombinant human H2 relaxin)
@en
P2093
P2860
P304
P356
10.1111/BPH.13404
P407
P577
2016-02-17T00:00:00Z